Join us:
January 10–12, 2022 in-person in San FranciscoJanuary 17–19, 2022 virtually

About the 2022 Program

The 2022 Biotech Showcase program will include in-person sessions January 10–12, 2022 in San Francisco. Select program sessions will be released on our proprietary partneringONE® platform as early as mid-December.   

Going live nearly two years after the COVID-19 pandemic first started, the 2022 program will feature insights from top investors and biopharma executives by: 

  • Examining how the biopharma industry can accelerate drug discovery and manufacturing to prepare for future pandemics.  

  • Providing updates in hot therapeutic areas such as oncology, CNS, cell and gene therapy, rare disease. 

  • Exploring how COVID-19 accelerated the adoption of all things digital through the Digital Medicine & Medtech Showcase program.  

  • Showcasing the promise of early-stage innovation through the Seed Showcase program. 

The 2022 program dates and times will be released by early fall of 2021. 

Event Timeline


  

2021 Program Highlights

45+

Digital Sessions

180+

Speakers

36

Hours of session content

THE BIOTECH SHOWCASE FAMILY OF EVENTS

Your Biotech Showcase registration showcase registration gives you access Biotech Showcase, Digital Medicine and Medtech Showcase and Seed Showcase content. China Showcase is a separate registration. 

BIOTECH SHOWCASE

DIGITAL MEDICINE AND MEDTECH SHOWCASE

SEED SHOWCASE

CHINA SHOWCASE

View these 2021 sessions

INVESTING IN DIVERSITY

RARE BEYOND THE SQUARE

From de-risking to value creation – The evolving role of patient communities in rare disease drug development and commercialization

DIGITAL HEALTH'S INVESTMENT OUTLOOK

MEDIA ROUND-UP